Trace Genomics
Burlingame
About Trace Genomics
Trace Genomics is specializing in soil health and microbiome analysis. They focus on providing advanced genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield and sustainability. Trace Genomics utilizes next-generation sequencing technologies to analyze the microbial composition of soil, offering information about the diversity and abundance of microorganisms present. This data can be valuable for farmers in making informed decisions about soil management, crop selection, and the application of fertilizers and other inputs. The company aims to empower farmers with actionable information to enhance soil health, increase crop productivity, and contribute to sustainable agriculture practices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.2M
- Funding stage: M&A
- Last round: Series B (Feb 2024)
- Website: tracegenomics.com
- Phone: +1 650 332 6661
Industries & Categories
Agriculture, AgTech, Biotechnology, Farming
Social Profiles
Canonical: https://fsome.com/organization/trace-genomics-52893 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.